Izland -
izlandi -
LYFJASTOFNUN (Icelandic Medicines Agency)
enalapril krka tafla 2,5 mg
krka sverige ab - enalaprilum maleat - tafla - 2,5 mg
Izland -
izlandi -
LYFJASTOFNUN (Icelandic Medicines Agency)
valpress filmuhúðuð tafla 160 mg
teva b.v.* - valsartanum inn - filmuhúðuð tafla - 160 mg
Izland -
izlandi -
LYFJASTOFNUN (Icelandic Medicines Agency)
valpress filmuhúðuð tafla 80 mg
teva b.v.* - valsartanum inn - filmuhúðuð tafla - 80 mg
Izland -
izlandi -
LYFJASTOFNUN (Icelandic Medicines Agency)
valsartan jubilant filmuhúðuð tafla 160 mg
jubilant pharmaceuticals nv - valsartanum inn - filmuhúðuð tafla - 160 mg
Izland -
izlandi -
LYFJASTOFNUN (Icelandic Medicines Agency)
valsartan krka filmuhúðuð tafla 80 mg
krka sverige ab - valsartanum inn - filmuhúðuð tafla - 80 mg
Európai Unió -
izlandi -
EMA (European Medicines Agency)
entresto
novartis europharm limited - sacubitril, valsartan - hjartabilun - ace ii hemla, önnur sturtu, umboðsmenn starfa á renín-ace kerfi - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.
Európai Unió -
izlandi -
EMA (European Medicines Agency)
neparvis
novartis europharm limited - sacubitril, valsartan - hjartabilun - lyf sem hafa áhrif á renín-angíótensín kerfið - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5. adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.
Európai Unió -
izlandi -
EMA (European Medicines Agency)
tolura
krka, d.d., novo mesto - telmisartan - háþrýstingur - angíótensín ii blokkar, látlaus - hypertensiontreatment háþrýstingi í fullorðnir. hjarta preventionreduction á hjarta dánar í sjúklinga með:vart atherothrombotic hjarta sjúkdómur (sögu um kransæðastíflu eða útlæga slagæð sjúkdómur) eða;tegund 2 sykursýki með skjalfest miða líffæri.
Izland -
izlandi -
LYFJASTOFNUN (Icelandic Medicines Agency)
natrilix retard forðatafla 1,5 mg
les laboratoires servier - indapamidum inn - forðatafla - 1,5 mg
Izland -
izlandi -
LYFJASTOFNUN (Icelandic Medicines Agency)
losatrix filmuhúðuð tafla 100 mg
ratiopharm gmbh* - losartanum kalíum - filmuhúðuð tafla - 100 mg